chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore Shoulder; Felt Blah; This is a spontaneous report from a contactable consumer reporting same events under the same suspect product for 6 patients. This is Report 2 of 6. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced sore shoulder and felt blah. Caller stated after he got the shot, he had talked to several people. Caller stated he had a sister who was a CNA, a niece who was a RN and another niece that was a Nurse Practitioner. Caller stated his brother in law and mom also thought he should get his shot. Caller stated they said their shoulder got sore the next day and they felt blah but that was it. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
dizziness, weak in knees  Still experiencing  dizziness throughout every day. Now 3 months later. Like I?m tipping back on my heels.
I feel like I have a pinched nerve all the way down my arm/ cant even hold a cup/ pain also runs through her elbow and down to her thumb area; Arm sore/ pain in her arm that feels different then the soreness/Hand pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (I feel like I have a pinched nerve all the way down my arm/ cant even hold a cup/ pain also runs through her elbow and down to her thumb area), PAIN IN EXTREMITY (Arm sore/ pain in her arm that feels different then the soreness/Hand pain) and PYREXIA (Fever) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049C21A and 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced NEURALGIA (I feel like I have a pinched nerve all the way down my arm/ cant even hold a cup/ pain also runs through her elbow and down to her thumb area), PAIN IN EXTREMITY (Arm sore/ pain in her arm that feels different then the soreness/Hand pain) and PYREXIA (Fever). At the time of the report, NEURALGIA (I feel like I have a pinched nerve all the way down my arm/ cant even hold a cup/ pain also runs through her elbow and down to her thumb area), PAIN IN EXTREMITY (Arm sore/ pain in her arm that feels different then the soreness/Hand pain) and PYREXIA (Fever) outcome was unknown. Not Provided          Patient  takes tramadol for back pain. Treatment medicines were not reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: follow up received on 03-JUN-2021 .Added new events arm  sore, pyrexia, hand pain
I woke up 4am on April 6th 2021 to pee and I noticed blood after my pee. There was no blood in my pee or discoloration however I had to clean my penis tip with a tissue and noticed a blood cloth came out while I was wiping. This concerns me but that was the only time I saw blood, there was none afterward nor has it occur since then.
PATIENT FELT FAINT, HAD PALPITATIONS. EVENTUALLY FELT BETTER AND RETURNED HOME.
This is a spontaneous report received from a contactable consumer. A male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administration date 19Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: first dose and second dose of Bnt162b2 (Lot number: not reported), for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 19Nov2021, outcome "unknown", described as "Third dose of COVID-19 Vaccine administered"; LYMPHADENOPATHY (non-serious) with onset Nov2021, outcome "unknown", described as "Swollen lymph nodes". The event "swollen lymph nodes" was evaluated at the physician office visit. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient reported nerve pain in shoulder area that had not gone away. First reported soreness on January 23, 2014 but did not want to file report. Returned on 3-8-14 and said pain still had not gone away. Told her we would submit adverse event report.
One week post vax the pt developed a low grade fever, rash and fussiness. The pt was seen in an ER and by a pediatrician and diagnosed with viral symptoms. Additional information has been requested. Follow up info from the nurse practitioner indicated that "no adverse experience has occurred to this pt, only the too-early exposure to the vaccines." The viral symptoms he experienced in 08/18/2000 were resolved by the following day. No further info is expected.
small headache; low-grade fever; increased heart rate; little bit of mental fogginess; shallow, short breaths; my body was in a lot of pain; Pretty bad reaction; the arm the shot was in I almost couldn't move at all entire body couldn't move due to pain/some tenderness at the injection site if he presses on it; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 40-years-old male patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 02Apr2021 (at the age of 40-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history included Covid 19 infection (last year (2020). Concomitant medications were not reported. On an unspecified date of Apr2021, patient experienced arm the shot was in he almost couldn't move at all entire body couldn't move due to pain, some tenderness at the injection site if he presses on it. On 03Apr2021 patient experienced small headache, low-grade fever, increased heart rate, little bit of mental fogginess, shallow, short breaths, his body was in a lot of pain and pretty bad reaction. Patient reported adverse events that started on Saturday (03Apr2021) which include being in a lot of pain throughout his whole body with difficulty moving, but mostly in his arms, especially in the arm where he received the vaccine. He also reported a small headache, a low-grade fever of 99.2 degree F, increased heart rate, and a little bit of mental fogginess. He was most concerned about a change in his breathing which wasn't difficulty breathing but he describes it as shallow, short breaths. He refrained from a lot of activity over the weekend. His symptoms were less noticeable on Sunday, also improved on Monday, and are almost non-existent today beside some tenderness at the injection site if he presses on it. Of note, caller also reports that he had a Covid19 infection last year (2020). Patient would like to know if he should get the second shot, given his experience with the first? He had a side effect after the first dose of the vaccine. Should he get the second dose? The patient underwent lab tests and procedures which included heart rate: increased and pyrexia: 99.2 fahrenheit. The events outcome was reported as unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I started having shooting pains in my legs about 2 days after the shot. It progresses to numbness, shooting pains, pins and needles, weakness and heaviness in legs , feet, hands and arms, and progresses to some numbness in face and continues today. It happens off and on during the day.  A few days ago I woke up with extreme numbness on my legs and had a rapid heart rate so I went to the emergency room, but they took my blood pressure and heart rate and sent me home to make a PCP apt, which I did.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 04-OCT-2014, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2017, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Exacerbation of Myasthenia Gravis (flare) drooping left eye; stomach pain; Fever 103.1 for 10 hours then fever 100.0-101.4 for 24 hours; muscle weakness; fatigue; seeing double; headache; migraine; nausea; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: FH8020), via an unspecified route of administration, administered in Arm Right on 28Oct2021 at 10:00 (at the age of 58 years old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included myasthenia gravis, lupus cystitis, scleroderma, raynaud's phenomenon, intervertebral disc degeneration, fructose intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included prednisone, diltiazem, pyridostigmine, bromide, hydrochlorothiazide, triamterene and ezetimibe. The patient received second dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: ER2613) in right arm on 18March2021 at 2:30 for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: EN6200) in right arm on 22Feb2021 at 11:15 for covid-19 immunisation. bnt162b2 for covid-19 immunisation, lyrica and experienced drug hypersensitivity, gabapentin and experienced drug hypersensitivity. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced exacerbation of myasthenia gravis (flare) drooping left eye, stomach pain, fever 103.1 for 10 hours then fever 100.0-101.4 for 24 hours, muscle weakness, fatigue, seeing double, headache, migraine, nausea on 28Oct2021 14:00. 4 hours after vaccine -Fever 103.1 for 10 hours then fever 100.0-101.4 for 24 hours. Exacerbation of Myasthenia Gravis (flare) drooping left eye and muscle weakness, fatigue, seeing double, headache, migraine, nausea, stomach pain. The patient underwent lab tests and procedures which included body temperature result was 103.1  on 28Oct2021, body temperature result was 100.0-101.4 for 24 hours  on 28Oct2021. The patient did not receive any treatment for the events. Facility type Vaccine result was Hospital. The outcome of exacerbation of myasthenia gravis (flare) drooping left eye, stomach pain, fever 103.1 for 10 hours then fever 100.0-101.4 for 24 hours, muscle weakness, fatigue, seeing double, headache, migraine and nausea was recovering.
has Covid; has Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient in her 20's received bnt162b2 (Formulation: Solution for injection) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Withheld is in mid-twenties. May be half of #. Withheld currently has Covid. This is the second time they have gotten Covid. I believe they are at least fully vaccinated. Not sure if the first time was before or after vaccination.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "has Covid".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial misuse report received from a healthcare professional on 09 May 2013. It was reported that DAPTACEL was administered to an adult patient (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
I started with fatigue and tiredness. It progressed to joint aches in my shoulder and then all joints. I lost my sense of taste and smell which is only halfway back. This is the only symptom that is lingering. I did not take any medication. I had a runny stuffy nose which I still have. I have about 50% of my taste back.
Second dose 3 weeks apart from first one; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 3 weeks apart from first one) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 3 weeks apart from first one). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 3 weeks apart from first one) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided.
Pt rec'd the flu shot on 1/23/03, she was getting ready for bed at 10:30pm on Friday, 1/24 when she noticed a large lump-like swelling near the area of the flu shot. It was the size of half a lemon. On Sat 1/25 at 9:00am she called the Hlth Dept where she rec'd the shot and explained why she was calling and was told they would call me back, within 15 min. a Dr called and asked me about my symptoms. He told me to put ice on the area and if I was running a fever or if the area changed colors to go to the ER. He said it was too soon to think about an infection. He also mentioned something about a hematoma. On Monday went back to Hlth Dept to have someone look at the swollen area (swelling gone down somewhat) a nsg checked it out and had someone else look at it also and they agreed it looked ok to them that it did not look swollen to them. she was given a paper on the influenza shot.
Narrative:  Patient received two covid vaccines. Patient died 3 weeks after second dose. Unclear if death was related to vaccine. PMH included stage IIIC (T3N3M0) adenocarcinoma of the R lung (s/p carboplatin, pretrexed, durcalumab, XRT), RA 2/2 durvalumab, PE with recurrent epicardial/pleural effusions s/p pericardial window, now c/b worsening renal function and hyperkalemia
Terrible stomach spasms and cramping.  Nausea, vomiting, and fever.
Patient had swelling and pain of injection site >5cm about 8 hours after injection. 12-18 hours after injection developed dizziness, nausea and headache which lasted about 2 hours, he still had swelling and pain of arm at 4 days.
This is a spontaneous report from a contactable consumer or other non-HCP. A male patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# EL9269, expiry date: unknown), via an unspecified route of administration, on Feb 7, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On Feb 7, 2021, patient experienced pain in the arm and shoulder. His arm got better, with outcome of recovering. Follow-up attempts completed. No further information expected.
pt recvd vax; on 11jul95 devel fever; broke out in a vesicular rash on chest, back & face in the am;
SORENESS ALL OVER; UPSET STOMACH; THROWING UP; UNABLE TO EAT; STOMACH TIGHT; WEAKNESS; FEVER; BAD HEADACHE; This spontaneous report received from a patient concerned a 21 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 18-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAY-2021, the subject experienced soreness all over. On 25-MAY-2021, the subject experienced upset stomach. On 25-MAY-2021, the subject experienced throwing up. On 25-MAY-2021, the subject experienced unable to eat. On 25-MAY-2021, the subject experienced stomach tight. On 25-MAY-2021, the subject experienced weakness. On 25-MAY-2021, the subject experienced fever. On 25-MAY-2021, the subject experienced bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from soreness all over, weakness, fever, bad headache, upset stomach, throwing up, unable to eat, and stomach tight. This report was non-serious.
Vaccinated on 5/23/16 with HPV9 and Varicella. Developed rash (L) forearm on 5/26/16. No previous treatment. Referred to PCP for follow-up prn.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Sep2022 at 11:00 as dose 5 (booster), single (Lot number: GT5342) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.
This is a spontaneous report received from a noncontactable consumer or other non-HCP (patient) for a Pfizer sponsored program (159558). A female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), Mar 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced illness, onset Mar 2021, with outcome of unknown. Patient stated this past week she got sick and has been sick all week, but tested negative 4 days ago. "Do you think I should repeat the test?" Relevant laboratory tests and procedures available in the appropriate section. No follow-up attempts possible. No further information expected.
STEMI that occurred 24 hours after vaccination. Suspect coincidental but temporally related.
her last flu shot, got made her sick; Initial information was received on 14-Jan-2021 regarding an unsolicited valid serious case received from a consumer.  This case involved a 74 year old female patient for whom her last flu shot, got made her sick (illness) was reported, while she received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication (s) and family history were not provided.  At the time of the event, the patient had ongoing Pulmonary arterial hypertension.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiration date not reported via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient for whom her last flu shot, got made her sick (illness) was reported, unknown latency following the administration of INFLUENZA VACCINE.   The patient was hospitalized (caused or prolinged) for this event.  No relevant laboratory data was reported.   It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown.  There will be no information available on the batch number for this case.; Sender's Comments: This case concerns an 74 years old female patient who reported sickness after vaccination with INFLUENZA VACCINE from unknown manufacturer. The time to onset is unknown. At the time of event the patient had ongoing pulmonary arterial hypertension. Moreover, concomitant medications and laboratory tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of vaccine cannot be assessed.
This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a adult female patient who received SHINGRIX for prophylaxis. On 16th May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced diarrhea, chills and influenza-like symptoms. On an unknown date, the outcome of the diarrhea, chills and influenza-like symptoms were unknown. It was unknown if the reporter considered the diarrhea, chills and influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced severe shivers. The reporter would not provide any additional information but stated that her husband experienced the same side effects. This case has been linked with US2018151936, reported by same reporter.